Skip to main content

VRTX

Vertex Pharmaceuticals Inc / Ma

Company with tickers: VRTX

CIK
875320
CUSIP
92532F100
Shares Outstanding
253,805,417
13F Activity (30d)
439 filings 390 filers

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.

Funds holding VRTX

16 fund positions
Fund Balance Value % of Fund
Saba Capital Income & Opportunities Fund 342 $160,706 -0.04%
Saba Capital Income & Opportunities Fund II 282 $132,512 -0.05%
Guggenheim Strategic Opportunities Fund 40 $19,873 0.00%
Nuveen Core Equity Alpha Fund 460 $205,408 0.08%
Eaton Vance Tax-Managed Buy-Write Income Fund 1,809 $807,791 0.17%
Gabelli Healthcare & WellnessRx Trust 3,200 $1,428,928 0.97%
Gabelli Dividend & Income Trust 4,000 $1,786,160 0.07%
BlackRock Capital Allocation Term Trust 5,181 $2,313,524 0.15%
TRI-CONTINENTAL Corp 8,484 $3,788,445 0.20%
BlackRock ESG Capital Allocation Term Trust 8,998 $4,017,967 0.28%
abrdn Life Sciences Investors 9,163 $4,091,646 0.73%
abrdn Healthcare Investors 19,974 $8,919,190 0.78%
BlackRock Health Sciences Term Trust 20,900 $9,332,686 0.92%
BlackRock Health Sciences Trust 31,983 $14,281,689 2.68%
State Street(R) SPDR(R) S&P 500(R) ETF Trust 2,965,418 $1,324,177,754 0.20%
Invesco QQQ Trust, Series 1 5,351,474 $2,389,647,200 0.64%
Showing 1–16 of 16 positions